Amgen halts clinical studies of its stomach-cancer drug
November 25, 2014 at 14:57 PM EST
Biotech company Amgen Inc. said it is ending late-stage clinical studies of its experimental stomach-cancer treatment because of patient deaths...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.